References
- Andersen P. E., Bolstad B., Berg K. J., Justesen P., Thayssen P., Kloster Y. F. Iodixanol and ioxaglate in cardioangiography. A double-blind randomized phase III study. Clin. Radiol. 1993; 48: 268
- Beyer-Enke S. A., Zeitler E. Late adverse reactions to nonionic contrast media. A cohort analytic study. Eur. Radiol. 1993; 3: 237
- Bolstad B., Borch K. W., Grynne B. H., et al. Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium. An emphasis on European clinical phases I and II. Invest. Radiol. 1991; 26: S201
- Brinker J. A. Selection of a contrast agent in the cardiac catheterization laboratory. Am. J. Cardiol. 1990; 66: 26F
- Brogan W. C., III, Hillis L. D., Lange R. A. Contrast agents for cardiac catheterization. Conceptions and misconceptions. Am. Heart J. 1991; 122: 1129
- Bush W. H., Swanson D. P. Acute reactions to intravascular contrast media. Types, risk factors, recognition, and specific treatment. AJR 1991; 157: 1153
- Davies P., Richardson R. E. A randomized long-term study of acute and delayed reactions to a nonionic and an ionic medium (Abstract). Invest. Radiol. 1988; 23(Suppl. 1)209
- Hald J. K., Jakobsen J. Å., Andrew E., Stormorken H. Short communications. Adverse reactions to contrast media. Related to medium or procedure? Observations on a case. Br. J. Radiol. 1988; 61: 337
- Hill J. A. Nonionic contrast use in cardiac angiography. Invest. Radiol. 1993; 28(Suppl. 5)S48
- Hill J. A., Cohen M. B., Kou W. H., et al. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am. J. Cardiol. 1994; 74: 57
- Jørgensen N. P., Nossen J. Ø., Borch K. W., et al. Safety and tolerability of iodixanol in healthy volunteers with reference to two monomeric X-ray contrast media. Eur. J. Radiol. 1992; 15: 252
- Kløw N. E., Levorstad K., Berg K. J., et al. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol. 1993; 34: 72
- Lawrence V., Matthai W., Hartmaier S. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group. Invest. Radiol. 1992; 27: 2
- McCollough M., Davis P., Richardson R. A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br. J. Radiol. 1989; 62: 260
- Mikkonen R., Kontkanen T., Kivisaari L. Acute and late adverse reactions to low-osmolar contrast media. Acta Radiol. 1995; 36: 72
- Mitsumori M., Hayakawa K., Soga T., et al. Effects of contrast media on the RR and QT interval during coronary arteriography. Acta Radiol. 1991; 32: 120
- Nossen J. Ø., Aakhus T., Berg K. J., Jørgenssen N. P., Andrew E. Experience with iodixanol, a new nonionic dimeric contrast medium. Preliminary results from the human phase I study. Invest. Radiol. 1990; 25: S113
- Panto P. N., Davies P. Delayed reactions to urographic contrast media. Br. J. Radiol. 1986; 59: 41
- Thomsen H. S., Dorph S. High-osmolar and low-osmolar contrast media. An update on frequency of adverse drug reactions. Acta Radiol. 1993; 34: 205
- Tveit K., Bolz K.-D., Bolstad B., et al. Iodixanol in cardio-angiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol. 1994; 35: 614
- Wolf G. L., Arenson R. L., Cross A. P. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice. A comparison of adverse effects. AJR 1989; 152: 939
- Yoshikawa H. Late adverse reactions to nonionic contrast media. Radiology 1992; 183: 737